recently approved research projects
Over the last 9 months, Snowdome’s funding efforts have been concentrated on directing just over $1,000,000 into epigenetic treatments for Australians with blood cancers. Snowdome… Read More

Over the last 9 months, Snowdome’s funding efforts have been concentrated on directing just over $1,000,000 into epigenetic treatments for Australians with blood cancers. Snowdome… Read More
Since Snowdome began in 2010, we’ve been working hard to attain some significant achievements. With the generous help of our donors and supporters:- – 8… Read More
Dr Jake Shortt views haematology and blood cancers as one of the most complex aspects of medicine. He enjoys the intellectual challenge of researching blood… Read More
In June this year at the European Haematology Association meeting in Italy, Dr Melita Kenealy, project manager of the Victorian Epigenetics Group, presented the first… Read More
We are delighted to report that Dr Jake Shortt (pictured second from left with Snowdome CEO, Miriam Dexter, the Hon. David Davis and Snowdome Director,… Read More